In recent years, the birth control medications Yaz and Yasmin have been used by more than 100 million women.
Yasmin was first approved by the FDA in 2001 and Yaz, later, in 2006. They are manufactured and sold by Bayer Healthcare, a German drug company.
However, you may know that the FDA and leading health safety groups have warned about the risk of blood clots associated with these medications, and Bayer has paid nearly $1.75 billion to settle injury claims.
Yaz and Yasmin first became widely used when the drugs were marketed as birth control alternatives that promised women relief from PMS, bloating, and acne when compared to traditional oral contraceptives.
What makes Yaz and Yasmin different from other birth control medications is that others contain only one hormone, progestin, while Yaz and Yasmin are combination pills that use both estrogen and progestin to prevent ovulation and pregnancy
What's more, the type of progestin used in Yaz and Yasmin is different from other pills. And, in recent studies, this synthetic progestin hormone -- drospirenone -- has been linked to an increased risk of blood clots.
A blood clot can break loose, and move through the body to the lungs, leg or thigh, or brain, causing serious or even fatal problems including stroke, deep vein thrombosis, or pulmonary embolism.
The FDA, European Medicines Agency, British Medical Journal and New England Journal of Medicine have issued warnings against Yaz and Yasmin because of their link to blood clots.